Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06709716 · ClinicalTrials.gov registry record · Phase 4
Impact of Preoperative Quadratus Lumborum Block on Postoperative Opioid Consumption After Laparoscopic Hysterectomy
A Phase 4 study, sponsored by Walter Reed National Military Medical Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 76
- Enrollment target
NCT06709716: Clinical Trial Phase 4 study, sponsored by Walter Reed National Military Medical Center.
NCT06709716 is a Phase 4 study that has not yet begun recruiting, run by Walter Reed National Military Medical Center. The registered enrollment target is 76 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06709716, a Phase 4 study, has not yet begun recruiting, sponsored by Walter Reed National Military Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 76 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if preoperative nerve block (quadratus lumborum \[QL\] block) works to improve pain control during and after laparoscopic hysterectomy. The main questions it aims to answer are: Does QL block decrease the amount of narcotic medication needed during surgery? Does QL block decrease the amount of narcotic medication needed after surgery? Researchers will compare QL block to local injection of a numbing medication at each incision site (the current standard practice) to see if QL block works to decrease surgical pain. Participants will be randomly assigned to receive one of the two following interventions: 1. QL block before surgery with a long-acting numbing medicine (liposomal bupivacaine) and then injection of placebo (saline) at each incision site in the operating room. 2. QL block before surgery with placebo (saline) and then injection of local numbing medicine (bupivacaine) at each incision site in the operating room. Participants will also: * Visit the clinic/hospital for a pre-operative appointment, the surgical procedure, and a 4-6 week post-operative appointment (all standard visits even if not participating in research) * Complete a questionnaire electronically, or by phone, that takes \<10 minutes at the pre-operative appointment and on postoperative days 1, 3, 5, 14, and 4-6 weeks.
Primary Outcome
Total opioid dose, calculated in morphine equivalent dose, required during intraoperative anesthesia care
Interventions
- DRUG Quadratus Lumborum Block (QLB)
- DRUG Local Anesthetic Solution
- DRUG Quadratus lumborum block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2026-02 |
| Phase | Phase 4 |
What is known before NCT06709716 opens enrollment
NCT06709716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Quadratus Lumborum Block (QLB) is the first listed.
NCT06709716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06709716 about?
NCT06709716 is a clinical study titled "Impact of Preoperative Quadratus Lumborum Block on Postoperative Opioid Consumption After Laparoscopic Hysterectomy". The goal of this clinical trial is to learn if preoperative nerve block (quadratus lumborum \[QL\] block) works to improve pain control during and after laparoscopic hysterectomy. The main questions it aims to answer are: Does QL block decrease the amount of narcotic medication needed during surger...
What is the current status of trial NCT06709716?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2024-12-01. Estimated completion is 2026-02.
What interventions are being tested in trial NCT06709716?
The interventions under investigation include: Quadratus Lumborum Block (QLB) (DRUG), Local Anesthetic Solution (DRUG), Quadratus lumborum block (DRUG).
Who is sponsoring clinical trial NCT06709716?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06709716's enrollment target sits among peer trials
76 994th of 2000 higher than 999 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI